Dimitrios Kandylas

Dimitrios Kandylas currently serves as Vice President and Deputy Corporate General Counsel at Spyre Therapeutics since February 2024. Previously, Dimitrios held similar roles at Sanofi and Provention Bio, demonstrating expertise in corporate law, particularly within the life sciences sector, including M&A, commercial contracting, and compliance. Notable prior positions include Counsel at Lowenstein Sandler, where focus was on corporate and transactional matters, and Corporate Counsel at MetLife, overseeing investment-related agreements. Dimitrios’s career also encompasses significant experience as an associate at leading law firms, including Morgan, Lewis & Bockius and Sullivan & Cromwell. Academically, Dimitrios achieved a J.D. Summa Cum Laude and an MBA in Finance and Pharmaceutical Management from Rutgers University, along with a BA Magna Cum Laude from Binghamton University.